Correction to: Caspase/AIF/apoptosis pathway: a new target of puerarin for diabetes mellitus therapy

Correction to: Molecular Biology Reports (2019) 46:4787–4797 https://doi.org/10.1007/s11033-019-04925-1

Figures 5, 6, and 7 have mistakes in them, according to the original manuscript. Figures 5, 6, and 7 are corrected with this correction.

Fig. 5

Pathophysiological observation of the pancreas (HE stain, n = 10, × 400). The pancreas samples were collected on the 15th day. a Normal control; b model control; c 320 mg kg⁻¹ d⁻¹ of metformin; d 80 mg kg⁻¹ d^− 1 of PR. The results are presented as the mean ± S.E. *P < 0.05 compared with the model group; **P < 0.01 compared with the model group

Fig. 6

Observation of pancreatic ultrastructure. The pancreas samples were collected on the 15th day. The red arrows point to the mitochondria in the pancreatic cells. a Normal control; b model control; c 320 mg kg⁻¹ d⁻¹ of metformin; d 80 mg kg⁻¹ d⁻¹ of PR. The results are presented as the mean ± S.E (n = 10). *P < 0.05 compared with the model group; **P < 0.01 compared with the model group

Fig. 7

Observation of pancreatic apoptosis. The pancreas samples were collected on the 15th day. The red arrows point to the TUNEL-positive cells. a Normal control; b model control; c 320 mg kg⁻¹ d⁻¹ of metformin; d 80 mg kg⁻¹ d⁻¹ of PR. The results are presented as the mean ± S.E (n = 10). *P < 0.05 compared with the model group; **P < 0.01 compared with the model group

The original article has been corrected.